CLR Medical

Executive Summary

CLR Medical is a San Diego-based medical device company specializing in a proprietary system for thoracic irrigation through indwelling catheters, such as chest tubes, to manage hemothorax and other pleural collections. Founded in 2015, the company aims to simplify and improve the standard of care for trauma and post-surgical patients with retained blood in the chest cavity. The system addresses a significant clinical need, as current management of retained hemothorax often relies on multiple interventions, including additional drainage or surgery, which can lead to increased morbidity and healthcare costs. By providing a dedicated irrigation system, CLR Medical seeks to reduce complications, shorten hospital stays, and improve patient outcomes. The market for thoracic drainage and management is substantial, driven by the high incidence of trauma and cardiothoracic surgeries globally. CLR Medical's solution targets a niche but critical application within this space, positioning the company for growth as it gains clinical adoption. As a private company, CLR Medical has not disclosed funding or revenue, but its innovative approach and clear value proposition suggest potential for strategic partnerships or acquisition by larger players in the medical device industry. Key upcoming milestones include regulatory clearances and clinical validation, which will be critical to commercial success.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) clearance for the thoracic irrigation system70% success
• Q4 2026Publication of results from a pivotal clinical trial on hemothorax management60% success
• TBDStrategic distribution partnership with a major medical device company50% success